1662 related articles for article (PubMed ID: 10581077)
1. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.
Dong H; Zhu G; Tamada K; Chen L
Nat Med; 1999 Dec; 5(12):1365-9. PubMed ID: 10581077
[TBL] [Abstract][Full Text] [Related]
2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
4. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
[TBL] [Abstract][Full Text] [Related]
5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Ishida Y; Agata Y; Shibahara K; Honjo T
EMBO J; 1992 Nov; 11(11):3887-95. PubMed ID: 1396582
[TBL] [Abstract][Full Text] [Related]
6. PD-1 and its ligands in tolerance and immunity.
Keir ME; Butte MJ; Freeman GJ; Sharpe AH
Annu Rev Immunol; 2008; 26():677-704. PubMed ID: 18173375
[TBL] [Abstract][Full Text] [Related]
7. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Iwai Y; Ishida M; Tanaka Y; Okazaki T; Honjo T; Minato N
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12293-7. PubMed ID: 12218188
[TBL] [Abstract][Full Text] [Related]
8. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Topalian SL; Hodi FS; Brahmer JR; Gettinger SN; Smith DC; McDermott DF; Powderly JD; Carvajal RD; Sosman JA; Atkins MB; Leming PD; Spigel DR; Antonia SJ; Horn L; Drake CG; Pardoll DM; Chen L; Sharfman WH; Anders RA; Taube JM; McMiller TL; Xu H; Korman AJ; Jure-Kunkel M; Agrawal S; McDonald D; Kollia GD; Gupta A; Wigginton JM; Sznol M
N Engl J Med; 2012 Jun; 366(26):2443-54. PubMed ID: 22658127
[TBL] [Abstract][Full Text] [Related]
9. The blockade of immune checkpoints in cancer immunotherapy.
Pardoll DM
Nat Rev Cancer; 2012 Mar; 12(4):252-64. PubMed ID: 22437870
[TBL] [Abstract][Full Text] [Related]
10. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.
Taube JM; Anders RA; Young GD; Xu H; Sharma R; McMiller TL; Chen S; Klein AP; Pardoll DM; Topalian SL; Chen L
Sci Transl Med; 2012 Mar; 4(127):127ra37. PubMed ID: 22461641
[TBL] [Abstract][Full Text] [Related]
12. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
Liang SC; Latchman YE; Buhlmann JE; Tomczak MF; Horwitz BH; Freeman GJ; Sharpe AH
Eur J Immunol; 2003 Oct; 33(10):2706-16. PubMed ID: 14515254
[TBL] [Abstract][Full Text] [Related]
14. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.
Agata Y; Kawasaki A; Nishimura H; Ishida Y; Tsubata T; Yagita H; Honjo T
Int Immunol; 1996 May; 8(5):765-72. PubMed ID: 8671665
[TBL] [Abstract][Full Text] [Related]
15. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Brahmer JR; Drake CG; Wollner I; Powderly JD; Picus J; Sharfman WH; Stankevich E; Pons A; Salay TM; McMiller TL; Gilson MM; Wang C; Selby M; Taube JM; Anders R; Chen L; Korman AJ; Pardoll DM; Lowy I; Topalian SL
J Clin Oncol; 2010 Jul; 28(19):3167-75. PubMed ID: 20516446
[TBL] [Abstract][Full Text] [Related]
17. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ; Wei S; Dong H; Alvarez X; Cheng P; Mottram P; Krzysiek R; Knutson KL; Daniel B; Zimmermann MC; David O; Burow M; Gordon A; Dhurandhar N; Myers L; Berggren R; Hemminki A; Alvarez RD; Emilie D; Curiel DT; Chen L; Zou W
Nat Med; 2003 May; 9(5):562-7. PubMed ID: 12704383
[TBL] [Abstract][Full Text] [Related]
18. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.
Tamura H; Dong H; Zhu G; Sica GL; Flies DB; Tamada K; Chen L
Blood; 2001 Mar; 97(6):1809-16. PubMed ID: 11238124
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of antitumor immunity by CTLA-4 blockade.
Leach DR; Krummel MF; Allison JP
Science; 1996 Mar; 271(5256):1734-6. PubMed ID: 8596936
[TBL] [Abstract][Full Text] [Related]
20. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
